Article
CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection
1 Dec 2005
Abstract excerpt
The human chemokine receptors, CCR5 and CXCR4, are potential host targets for exogenous, small-molecule antagonists for the inhibition of HIV-1 infection. HIV-1 strains can be categorised by co-receptor tropism - their ability to utilise CCR5 (CCR5-tropic), CXCR4 (CXCR4-tropic) or both (dual-tropic) as a co-receptor for entry into susceptible cells. CCR5 may be the more suitable co-receptor target for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
